Systemic blood pressure in severe aortic stenosis: Haemodynamic correlates and long-term prognostic impact.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
Feb 2023
Historique:
revised: 10 09 2022
received: 29 07 2022
accepted: 21 09 2022
pubmed: 8 10 2022
medline: 26 1 2023
entrez: 7 10 2022
Statut: ppublish

Résumé

Blood pressure (BP) targets in patients with aortic stenosis (AS) are controversial. This study sought to describe the haemodynamic profile and the clinical outcome of severe AS patients with low versus high central meaarterial pressure (MAP). Patients with severe AS (n = 477) underwent right and left heart catheterization prior to aortic valve replacement (AVR). The population was divided into MAP quartiles. The mean systolic BP, diastolic BP, and MAP in the entire population were 149 ± 25, 68 ± 11, and 98 ± 14 mmHg. Patients in the lowest MAP quartile had the lowest left ventricular ejection fraction (LVEF), systemic vascular resistance, and valvulo-arterial impedance, whereas there were no significant differences in mean right atrial pressure, mean pulmonary artery wedge pressure, pulmonary vascular resistance, and stroke volume index across MAP quartiles. However, left ventricular stroke work index (LVSWI) was lowest in patients in the lowest and highest in those in the highest MAP quartile. After a median (interquartile range) post-AVR follow-up of 3.7 (2.6-5.2) years, mortality was highest in patients in the lowest MAP quartile [hazard ratio 3.08 (95% confidence interval 1.21-7.83); P = 0.02 for lowest versus highest quartile]. In the multivariate analysis, lower MAP [hazard ratio 0.78 (95% confidence interval 0.62-0.99) per 10 mmHg increase; P = 0.04], higher mean right atrial pressure and lower LVEF were independent predictors of death. In severe AS patients, lower MAP reflects lower systemic vascular resistance and valvulo-arterial impedance, which may help to preserve stroke volume and filling pressures despite reduced left ventricular performance, and lower MAP is a predictor of higher long-term post-AVR mortality.

Identifiants

pubmed: 36205069
doi: 10.1002/ehf2.14192
pmc: PMC9871666
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

274-283

Informations de copyright

© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

J Am Heart Assoc. 2019 Nov 5;8(21):e014020
pubmed: 31665959
Trends Cardiovasc Med. 2022 Feb;32(2):73-81
pubmed: 33346089
Circ Cardiovasc Imaging. 2020 Nov;13(11):e011642
pubmed: 33190537
JAMA Cardiol. 2018 Jun 1;3(6):453-454
pubmed: 29590308
J Am Coll Cardiol. 2005 Jul 19;46(2):291-8
pubmed: 16022957
Circulation. 2016 Aug 9;134(6):455-68
pubmed: 27486164
Circulation. 2013 Sep 17;128(12):1281-3
pubmed: 23956212
Circ Cardiovasc Imaging. 2017 Jul;10(7):
pubmed: 28701528
J Clin Med. 2021 Nov 26;10(23):
pubmed: 34884254
JACC Cardiovasc Interv. 2019 Nov 11;12(21):2145-2154
pubmed: 31699376
N Engl J Med. 2003 May 1;348(18):1756-63
pubmed: 12724481
Circulation. 2012 May 15;125(19):2353-62
pubmed: 22447809
J Hypertens. 2016 Aug;34(8):1497-9
pubmed: 27355998
Eur Heart J. 2017 Apr 14;38(15):1132-1143
pubmed: 28158398
Circulation. 1992 Aug;86(2):513-21
pubmed: 1638719
J Hypertens. 2020 Jul;38(7):1211-1219
pubmed: 32205564
JACC Heart Fail. 2017 Nov;5(11):795-801
pubmed: 29032138
Circulation. 2012 May 15;125(19):2295-7
pubmed: 22586290
Eur J Heart Fail. 2022 Mar;24(3):581-588
pubmed: 34693613
ESC Heart Fail. 2023 Feb;10(1):274-283
pubmed: 36205069
Lancet. 2003 Apr 12;361(9365):1241-6
pubmed: 12699950
Circulation. 2013 Sep 17;128(12):1349-53
pubmed: 23956211
Eur J Heart Fail. 2019 Feb;21(2):172-181
pubmed: 30328215
BMJ Open. 2020 Oct 5;10(10):e036960
pubmed: 33020089
Circulation. 1980 Mar;61(3):536-42
pubmed: 7353244
J Am Coll Cardiol. 2019 Aug 6;74(5):631-641
pubmed: 31370954
Eur J Cardiothorac Surg. 2021 Oct 22;60(4):727-800
pubmed: 34453161
CJC Open. 2021 Jul 10;3(12):1428-1437
pubmed: 34993454
Circ Heart Fail. 2017 Sep;10(9):
pubmed: 28912262
J Am Coll Cardiol. 2009 Sep 8;54(11):1003-11
pubmed: 19729117

Auteurs

Micha T Maeder (MT)

Cardiology Department, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Hans Rickli (H)

Cardiology Department, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Lukas Weber (L)

Cardiology Department, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Daniel Weilenmann (D)

Cardiology Department, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Peter Ammann (P)

Cardiology Department, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Lucas Joerg (L)

Cardiology Department, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Philipp K Haager (PK)

Cardiology Department, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Johannes Rigger (J)

Cardiology Department, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Joannis Chronis (J)

Cardiology Department, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Roman Brenner (R)

Cardiology Department, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH